Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.

Orme M, Fenici P, Lomon ID, Wygant G, Townsend R, Roudaut M.

Diabetol Metab Syndr. 2014 Jun 11;6:73. doi: 10.1186/1758-5996-6-73. eCollection 2014. Review.

PMID:
25006351
[PubMed]
Free PMC Article
2.

Dapagliflozin added to glimepiride in patients with type 2 diabetes mellitus sustains glycemic control and weight loss over 48 weeks: a randomized, double-blind, parallel-group, placebo-controlled trial.

Strojek K, Yoon KH, Hruba V, Sugg J, Langkilde AM, Parikh S.

Diabetes Ther. 2014 Jun;5(1):267-83. doi: 10.1007/s13300-014-0072-0. Epub 2014 Jun 12.

PMID:
24920277
[PubMed]
Free PMC Article
3.

Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action.

Fujita Y, Inagaki N.

J Diabetes Investig. 2014 May 4;5(3):265-75. doi: 10.1111/jdi.12214. Epub 2014 Apr 2. Review.

PMID:
24843771
[PubMed]
Free PMC Article
4.

Patient considerations in the management of type 2 diabetes - critical appraisal of dapagliflozin.

Salvo MC, Brooks AD, Thacker SM.

Patient Prefer Adherence. 2014 Apr 22;8:493-502. doi: 10.2147/PPA.S59169. eCollection 2014. Review.

PMID:
24790417
[PubMed]
Free PMC Article
5.

The efficacy of dapagliflozin combined with hypoglycaemic drugs in treating type 2 diabetes mellitus: meta-analysis of randomised controlled trials.

Sun YN, Zhou Y, Chen X, Che WS, Leung SW.

BMJ Open. 2014 Apr 7;4(4):e004619. doi: 10.1136/bmjopen-2013-004619.

PMID:
24710132
[PubMed]
Free PMC Article
6.

Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus.

Reilly TP, Graziano MJ, Janovitz EB, Dorr TE, Fairchild C, Lee F, Chen J, Wong T, Whaley JM, Tirmenstein M.

Diabetes Ther. 2014 Jun;5(1):73-96. doi: 10.1007/s13300-014-0053-3. Epub 2014 Jan 29.

PMID:
24474422
[PubMed]
Free PMC Article
7.

SGLT-2 inhibitors and their potential in the treatment of diabetes.

Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ.

Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. Review.

PMID:
24348059
[PubMed]
Free PMC Article
8.
9.

Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus.

Bays H.

Diabetes Ther. 2013 Dec;4(2):195-220. doi: 10.1007/s13300-013-0042-y. Epub 2013 Oct 19.

PMID:
24142577
[PubMed]
Free PMC Article
10.

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.

Kohan DE, Fioretto P, Tang W, List JF.

Kidney Int. 2014 Apr;85(4):962-71. doi: 10.1038/ki.2013.356. Epub 2013 Sep 25.

PMID:
24067431
[PubMed - in process]
Free PMC Article
11.

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.

Yale JF, Bakris G, Cariou B, Yue D, David-Neto E, Xi L, Figueroa K, Wajs E, Usiskin K, Meininger G.

Diabetes Obes Metab. 2013 May;15(5):463-73. doi: 10.1111/dom.12090. Epub 2013 Mar 28.

PMID:
23464594
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.

Bailey CJ, Gross JL, Hennicken D, Iqbal N, Mansfield TA, List JF.

BMC Med. 2013 Feb 20;11:43. doi: 10.1186/1741-7015-11-43. Erratum in: BMC Med. 2013;11:193.

PMID:
23425012
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A review of the efficacy and safety of oral antidiabetic drugs.

Stein SA, Lamos EM, Davis SN.

Expert Opin Drug Saf. 2013 Mar;12(2):153-75. doi: 10.1517/14740338.2013.752813. Epub 2012 Dec 14. Review.

PMID:
23241069
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes.

Clar C, Gill JA, Court R, Waugh N.

BMJ Open. 2012 Oct 18;2(5). pii: e001007. doi: 10.1136/bmjopen-2012-001007. Print 2012.

PMID:
23087012
[PubMed]
Free PMC Article
15.

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes.

Kim Y, Babu AR.

Diabetes Metab Syndr Obes. 2012;5:313-27. doi: 10.2147/DMSO.S22545. Epub 2012 Aug 31.

PMID:
22977310
[PubMed]
Free PMC Article
16.

Pharmacotherapy for childhood obesity: present and future prospects.

Sherafat-Kazemzadeh R, Yanovski SZ, Yanovski JA.

Int J Obes (Lond). 2013 Jan;37(1):1-15. doi: 10.1038/ijo.2012.144. Epub 2012 Aug 28. Review.

PMID:
22929210
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus.

Whaley JM, Tirmenstein M, Reilly TP, Poucher SM, Saye J, Parikh S, List JF.

Diabetes Metab Syndr Obes. 2012;5:135-48. doi: 10.2147/DMSO.S22503. Epub 2012 Jul 23.

PMID:
22923998
[PubMed]
Free PMC Article
18.

Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes.

Chao EC.

Core Evid. 2012;7:21-8. doi: 10.2147/CE.S16359. Epub 2012 Jun 1.

PMID:
22701099
[PubMed]
Free PMC Article
19.

Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy.

Rosenstock J, Vico M, Wei L, Salsali A, List JF.

Diabetes Care. 2012 Jul;35(7):1473-8. doi: 10.2337/dc11-1693. Epub 2012 Mar 23.

PMID:
22446170
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

SGLT-2 inhibitors in development for type 2 diabetes treatment.

Bhartia M, Tahrani AA, Barnett AH.

Rev Diabet Stud. 2011 Fall;8(3):348-54. doi: 10.1900/RDS.2011.8.348. Epub 2011 Nov 10. Review.

PMID:
22262072
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk